Epo is involved in angiogenesis in human glioma (Q48135959)

9 February 2018

title

Epo is involved in angiogenesis in human glioma (English)

1 reference

9 February 2018

author

Tiziana Annese

2

1 reference

9 February 2018

Diego Guidolin

3

1 reference

9 February 2018

Domenico Ribatti

6

object named as

Domenico Ribatti

1 reference

9 February 2018

Beatrice Nico

1

1 reference

9 February 2018

Nicoletta Finato

4

1 reference

9 February 2018

Enrico Crivellato

5

1 reference

9 February 2018

publication date

9 July 2010

1 reference

9 February 2018

Journal of Neuro-Oncology

published in

1 reference

9 February 2018

volume

102

1 reference

9 February 2018

issue

1

1 reference

9 February 2018

page(s)

51-58

1 reference

9 February 2018

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

1 reference

Angiogenesis in gliomas: biology and molecular pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Antiangiogenesis: biology and utility in the treatment of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Genetic and biologic progression in astrocytomas and their relation to angiogenic dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Quantitative analysis of tight junctions and the uptake of 99mTc in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

A transmission and scanning electron microscopic study of tumoral and peritumoral microblood vessels in human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Extracellular matrix and the blood-brain barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Erythropoietin, the first century.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Erythropoietin and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

In vivo evidence that erythropoietin protects neurons from ischemic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

A potential role for erythropoietin in focal permanent cerebral ischemia in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

The new WHO classification of brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Opposite patterns of age-associated changes in neurons and glial cells of the thalamus of human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Placenta growth factor activates monocytes and correlates with sickle cell disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Inhibition of erythropoietin signalling destroys xenografts of ovarian and uterine cancers in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Erythropoietin is involved in growth and angiogenesis in malignant tumours of female reproductive organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Pediatric Tumor Cells Express Erythropoietin and a Functional Erythropoietin Receptor that Promotes Angiogenesis and Tumor Cell Survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Immunolocalization of erythropoietin and erythropoietin receptor in vestibular schwannoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Erythropoietin regulates tumour growth of human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Erythropoietin promotes the growth of tumors lacking its receptor and decreases survival of tumor-bearing mice by enhancing angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Does erythropoietin accelerate malignant transformation in multiple myeloma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Erythropoietin-dependent transformation of myelodysplastic syndrome to acute monoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Intussusceptive microvascular growth in human glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0294-6

Glioblastoma multiforme cells: expression of erythropoietin receptor and response to erythropoietin.

21 January 2018

1 reference

12 December 2020

A potential role of erythropoietin in angiogenesis associated with myelodysplastic syndromes

1 reference

12 December 2020

Erythropoietin stimulates proliferation of human renal carcinoma cells

1 reference

12 December 2020

Functional significance of erythropoietin receptor expression in breast cancer

1 reference

12 December 2020

Analysis of expression of erythropoietin-binding sites in human lung carcinoma by the biotinylated ligand

1 reference

12 December 2020

Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function

1 reference

12 December 2020

Erythropoietin therapy for acute stroke is both safe and beneficial

1 reference

12 December 2020

Recombinant human erythropoietin induces intussusceptive microvascular growth in vivo

1 reference

12 December 2020

Delayed vascular changes after antiangiogenic therapy with antivascular endothelial growth factor antibodies in human glioma xenografts in nude mice

1 reference

12 December 2020

10.1007/S11060-010-0294-6

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018